Valeant Used 'Clandestine Network' To Cook Books, Says Suit
Valeant Pharmaceuticals International Inc. misrepresented to investors that its growth was driven by acquisitions rather than by deceptive sales practices, ultimately causing shares to plunge more than 90 percent, shareholders claimed...To view the full article, register now.
Already a subscriber? Click here to view full article